List of works by Benjamin Maasoumy

A175 CAN HCV CORE ANTIGEN REPLACE HCV RNA TESTING IN THE ERA OF DIRECT-ACTING ANTIVIRALS?

Applicability of Hepatitis C Virus RNA Viral Load Thresholds for 8-Week Treatments in Patients With Chronic Hepatitis C Virus Genotype 1 Infection.

scientific article

Association Between Type 2 Diabetes Mellitus, HbA1c and the Risk for Spontaneous Bacterial Peritonitis in Patients with Decompensated Liver Cirrhosis and Ascites

scientific article published on 24 September 2018

Clinical significance of detectable and quantifiable HCV RNA at the end of treatment with ledipasvir/sofosbuvir in GT1 patients

scientific article published on 10 August 2018

Clinical utility of HCV core antigen detection and quantification in the diagnosis and management of patients with chronic hepatitis C receiving an all-oral, interferon-free regimen.

scientific article published on 26 April 2016

Commentary: detection of low level viraemia in telaprevir-based triple therapy for hepatitis C virus - authors' reply

scientific article published on March 2014

Commutability and concordance of four hepatitis B virus DNA assays in an international multicenter study

scientific article

Detection of low HCV viraemia by repeated HCV RNA testing predicts treatment failure to triple therapy with telaprevir.

scientific article published on 10 November 2013

Diagnostics in hepatitis C: The end of response-guided therapy?

scientific article published on October 2016

Dominance of hepatitis C virus (HCV) is associated with lower quantitative hepatitis B surface antigen and higher serum interferon-γ-induced protein 10 levels in HBV/HCV-coinfected patients

scientific article published on 13 April 2015

Dose-dependent impact of proton pump inhibitors on the clinical course of spontaneous bacterial peritonitis.

scientific article

Drug-Drug Interactions With Novel All Oral Interferon-Free Antiviral Agents in a Large Real-World Cohort.

scientific article published on 26 November 2015

Editorial: pressure to close the therapeutic window of non-selective beta blockers? Authors' reply

scientific article published on 01 October 2019

Editorial: retreatment of DAA-failures-no problem at all?

scientific article published on 01 June 2018

Eligibility and safety of the first interferon-free therapy against hepatitis C in a real-world setting

scientific article published on 2 February 2015

Eligibility and safety of triple therapy for hepatitis C: lessons learned from the first experience in a real world setting

scientific article

Evaluation of the COBAS(®) AmpliPrep/COBAS(®) TaqMan(®) HCV Test, v2.0 and comparison to assays used in routine clinical practice in an international multicenter clinical trial: The ExPECT study.

scientific article published on 31 March 2015

HBV-RNA Co-amplification May Influence HBV DNA Viral Load Determination

scientific article published on 26 May 2020

HCV core antigen as an alternate test to HCV RNA for assessment of virologic responses to all-oral, interferon-free treatment in HCV genotype 1 infected patients

scientific article published on 27 March 2017

HCV core antigen as an alternative to HCV RNA testing in the era of direct-acting antivirals: retrospective screening and diagnostic cohort studies

scientific article published on 28 September 2018

Hepatitis B core-related antigen (HBcrAg) levels in the natural history of hepatitis B virus infection in a large European cohort predominantly infected with genotypes A and D.

scientific article published on 17 February 2015

Hepatitis C RNA assay differences in results: Potential implications for shortened therapy and determination of Sustained Virologic Response

scientific article published on 20 October 2016

How to interpret borderline HCV antibody test results: a comparative study investigating four different anti-HCV assays.

scientific article published on February 2014

Letter: Telaprevir triple therapy in chronic hepatitis C genotype 1 patients receiving haemodialysis

scientific article published in June 2014

Limited effectiveness and safety profile of protease inhibitor-based triple therapy against chronic hepatitis C in a real-world cohort with a high proportion of advanced liver disease.

scientific article published on August 2014

MAIT cells are enriched and highly functional in ascites of patients with decompensated liver cirrhosis

scientific article published on 03 February 2020

Multicenter Comparison Study of both Analytical and Clinical Performance across Four Roche Hepatitis C Virus RNA Assays Utilizing Different Platforms.

scientific article published on 25 January 2017

New direct-acting antiviral agents for the treatment of chronic hepatitis C in 2014

scientific article published in April 2014

New viral biomarkers for Hepatitis B: Are we able to change practice?

scientific article published on 01 November 2018

Optimal treatment with boceprevir for chronic HCV infection.

scientific article published on February 2013

Performance of two HCV RNA assays during protease inhibitor-based triple therapy in patients with advanced liver fibrosis and cirrhosis.

scientific article

Renal function in HCV therapy: Just another thing to ignore?

scientific article published on 01 May 2020

Reply to: "HCV RNA kinetics on-treatment do not predict sustained virologic response in HCV genotype 3 patients receiving sofosbuvir and ribavirin".

scientific article published on 23 July 2016

Sustained impact of nosocomial-acquired spontaneous bacterial peritonitis in different stages of decompensated liver cirrhosis

scientific article published on 02 August 2019

Systemic arterial blood pressure determines the therapeutic window of non-selective beta blockers in decompensated cirrhosis

scientific article published on 02 August 2019

The clinical significance of drug-drug interactions in the era of direct-acting anti-viral agents against chronic hepatitis C.

scientific article published on 16 October 2013

The impact of proton pump inhibitors on the intestinal microbiota in chronic hepatitis C patients

scientific article published on 30 July 2019

Treatment of Chronic Hepatitis C: Efficacy, Side Effects and Complications

scientific article published on 21 May 2019

Treatment of naïve patients with chronic hepatitis C genotypes 2 and 3 with pegylated interferon alpha and ribavirin in a real world setting: relevance for the new era of DAA

scientific article

Utility of viral kinetics in HCV therapy - It is not over until it is over?

scientific article published on 01 May 2019

Viral and Host Responses After Stopping Long-term Nucleos(t)ide Analogue Therapy in HBeAg-Negative Chronic Hepatitis B.

scientific article

What is new on HBsAg and other diagnostic markers in HBV infection?

scientific article published on 04 May 2017

Paulina is supported by:

About Paulina

Help